ac investment research

Should I Buy NASDAQ:GNMK Stock? (16% Forecasted Return) | GNMK GenMark Diagnostics Stock Forecast



For companies that engage in reverse factoring--where accounts payable (AP) days are extended beyond the term customary for the industry and supply chain--we assess the likelihood and potential impact on liquidity of these arrangements ceasing to exist. In such a scenario, a company could be subject to material working capital outflows if AP days with its suppliers revert back to industry norms. Accordingly, we exclude these arrangements from sources of liquidity.Investments should be able to be quickly liquidated without requiring deep discounts to their carrying value. This does not preclude long-term investments from being included. It does, however, exclude large stakes in non-liquid equity investments. We estimate GNMK GenMark Diagnostics stock forecast parameters by: Momentum with ElasticNet Regression because we use the multipliers stemming from the Gaussian distribution (with a 50% add-on for fat tail events) to transform a VaR at a x-confidence level into a VaR at the chosen confidence level (16% Forecasted Return)

NASDAQ:GNMK Stock Forecast (Buy or Sell) as of 22 Jun 2022 for (n+16 weeks)

Stock: GNMK GenMark Diagnostics

Time series to forecast n: 22 Jun 2022 for (n+16 weeks)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %

Stock Forecast Criteria and Models for GNMK GenMark Diagnostics

  • In certain exceptional cases, we may consider deducting a greater amount of DTAs that arise from timing differences than the amount resulting from the calculation in the previous paragraphs. This may be the case when both the regulatory deduction of such DTAs (that arise from timing differences) is higher than the deduction described in the previous paragraph and we consider that this higher deduction appropriately reflects the risks of unexpected losses embedded in the stock of DTAs accumulated by the institution.
  • Derivatives receivables represent more than 0.5% of total assets for entities reporting under U.S. GAAP.
  • We do not adjust capital for servicing assets that are included in the reported goodwill or intangible assets figures
  • Trends over time and peer comparisons may be part of the quantitative analysis for both business and governmental entities.
  • Even in cases where regulatory approval is required for any redemption, the Hybrid Documentation stipulates that it may only be replaced by issuing new common equity instruments or by an equivalent or stronger instrument
  • In addition, for sovereign obligors, consideration of political risks may include an assessment of the potential for war, revolution, or other security-related events to affect creditworthiness. Other qualitative considerations that may be part of an analysis of a governmental obligor include revenue forecasting, expenditure control, long-term capital planning, debt management, and contingency planning. Finally, the assessment of a governmental obligor focuses on the potential that the obligor might default even when it has the resources to meet its financial commitments.
  • If we consider that the payment risk (that is, the likelihood of loss absorption or cash conservation) for a specific instrument is not reflected in either the starting point or the minimum notching, we apply wider notching at issuance. We may also revise the notching as part of our surveillance if the payment risk increases or decreases over the life of the instrument. We do not impose a limit on the number of notches that we may deduct for payment risk.

Assumptions Underlying The Forecast Model for GNMK GenMark Diagnostics

When determining the cash to be included under sources (A), we use cash that will be available to cover monetary outflows. As a result, we may make haircuts to account for cash trapped overseas (for example, haircut for taxes payable upon repatriation of cash held abroad), apply a discount to lower-quality marketable securities, and exclude restricted cash held for specific purposes.

Frequently Asked QuestionsQ: Is GNMK GenMark Diagnostics stock buy or sell?
A: For companies that engage in reverse factoring--where accounts payable (AP) days are extended beyond the term customary for the industry and supply chain--we assess the likelihood and potential impact on liquidity of these arrangements ceasing to exist. In such a scenario, a company could be subject to material working capital outflows if AP days with its suppliers revert back to industry norms. Accordingly, we exclude these arrangements from sources of liquidity.
Q: Is GNMK GenMark Diagnostics stock expected to go up?
A: Investments should be able to be quickly liquidated without requiring deep discounts to their carrying value. This does not preclude long-term investments from being included. It does, however, exclude large stakes in non-liquid equity investments.
Q: What is the forecast for GNMK GenMark Diagnostics ?
A: When determining the cash to be included under sources (A), we use cash that will be available to cover monetary outflows. As a result, we may make haircuts to account for cash trapped overseas (for example, haircut for taxes payable upon repatriation of cash held abroad), apply a discount to lower-quality marketable securities, and exclude restricted cash held for specific purposes.
Q: What is the consensus rating of GNMK GenMark Diagnostics ?
A: The consensus rating for GNMK GenMark Diagnostics is 77.
Q: What are the risks of investing GNMK GenMark Diagnostics ?
A: We use risk analysis for GNMK GenMark Diagnostics because we use the multipliers stemming from the Gaussian distribution (with a 50% add-on for fat tail events) to transform a VaR at a x-confidence level into a VaR at the chosen confidence level


GNMK GenMark Diagnostics
AC Investment Research

In our experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com